Vita Capital VI Limited

Share

S&P takes Vita Capital VI mortality bond off negative watch as Covid-19 outlook improves

The first catastrophe bond rating action caused by the Covid-19 coronavirus pandemic has now been resolved and reverted, as S&P Global Ratings affirmed Swiss Re’s late 2015 Vita Capital VI Limited (Series 2015-1) transaction and removed it from a negative watch. The mortality catastrophe bond which featured a single $100 million read the full article →

Swiss Re’s Vita Capital VI mortality bond on negative watch on Covid-19: S&P

The first catastrophe bond rating action due to the Covid-19 coronavirus pandemic is unsurprisingly related to one of the few mortality cat bonds left in the market, Swiss Re's late 2015 Vita Capital VI Limited (Series 2015-1) transaction, which has been put on a negative watch by S&P Global Ratings. The read the full article →

Vita Capital VI mortality bond remains $100m, prices below mid-point

Global reinsurance firm Swiss Re's latest catastrophe bond, the Vita Capital VI Limited (Series 2015-1) extreme mortality transaction, has remained at $100 million in size and the coupon pricing has been fixed at just below the middle of initial guidance. Swiss Re's new Vita Capital deal, its first mortality cat bond read the full article →

Swiss Re launches Vita Capital VI excess mortality catastrophe bond

One of the world's largest reinsurance companies Swiss Re is returning to the capital markets with its first excess mortality catastrophe bond transaction since 2012, seeking at least $100 million of retrocession through a Vita Capital VI Limited (Series 2015-1) issuance. This is the first Vita Capital mortality cat bond since read the full article →